Nature Reviews Gastroenterology & Hepatology

Papers
(The H4-Index of Nature Reviews Gastroenterology & Hepatology is 73. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Genetic factors in alcohol-related cirrhosis1160
Crosstalk between enteric neurons and colorectal cancer stem cells influences self-renewal864
Regulating protease homeostasis in irritable bowel syndrome695
Detecting gut osmolality changes to quench thirst584
No beneficial effect of G-CSF in treating ACLF531
Showing a sensitive side459
Understanding remodelling of bile ducts to promote polycystic liver disease403
New potent HBV replication inhibitors for the management of chronic hepatitis B are needed378
Helicobacter pylori, microbiota and gastric cancer — principles of microorganism-driven carcinogenesis340
The challenges facing female transplant hepatologists as young faculty313
Rectally shed SARS-CoV-2 lacks infectivity: time to rethink faecal–oral transmission?311
Mirikizumab for inducing and maintaining clinical remission in ulcerative colitis288
Hybrid EASL Congress 2023288
Neuropod cells — sensing a sweet spot in the gut284
Western lifestyle, metaflammation and the cell of origin of colon cancer282
Author Correction: Towards unifying fatty liver nomenclature: a voice from the Middle East and North Africa280
Hybrid APASL meeting 2024260
Artificial intelligence and automation in endoscopy and surgery242
Pouchitis: pathophysiology and management234
Genetics, pathobiology and therapeutic opportunities of polycystic liver disease233
Effect of bariatric surgery on risk of oesophagogastric cancer232
A role for the gut microbiota in immune checkpoint inhibitor-induced colitis223
Justice, equity, diversity and inclusion in gastroenterology and hepatology199
Mapping neuroimmune interactions in the gut192
Anti-SARS-CoV-2 vaccine in liver transplantation181
Promoting allyship to support and uplift the LGBTQIA+ community176
Rhythmicity of infant microbiota and dietary effects171
Telemedicine for hepatitis C virus treatment in opioid treatment programmes160
Insight into virome development158
Long-term normothermic liver perfusion152
Celebrating 20 years of Nature Reviews Gastroenterology & Hepatology151
Zolbetuximab treatment in metastatic gastric cancer143
Human hepatocyte organoids model early NAFLD143
Comparing elimination diet therapies for eosinophilic oesophagitis139
A serious side to social media135
Sphingolipids in hepatic metabolism133
Molecular landscape of NASH-HCC130
A gut–liver axis in intestinal stem cell fitness129
2023 FDA approvals in gastroenterology and hepatology125
Disability inclusion in research and health care123
Contrasting aspects of human excreta123
Metabolism of 5-ASA by the gut microbiome121
Immunosuppressive IBD drugs and COVID-19 vaccine immunogenicity119
High-density lipoprotein lipidome: a neglected source of hepatic lipids119
Fetal liver development and implications for liver disease pathogenesis117
Exploring liver cancer biology through functional genetic screens113
ZBTB46+ ILC3s promote intestinal health109
Vaccination at the forefront of the fight against hepatitis B and C107
Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus107
Author Correction: The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics104
Towards unifying fatty liver nomenclature: a voice from the Middle East and North Africa103
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease102
Achieving health equity in liver disease pharmacotherapy97
Hepatitis D virus: more attention needed95
Single-cell RNA sequencing in pancreatic cancer94
Medical images, social media and consent91
Is less more? Challenging dogma for individualized fluid resuscitation91
Author Correction: Improving IBD outcomes in the era of many treatment options90
Dietary and metabolic effects on intestinal stem cells in health and disease88
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases87
Jumping the chasm from postdoc to PI86
Inter-disciplinary collaboration for innovation in gastroenterology86
Alcohol-free and low-strength drinks: friend or foe?85
Unlocking CD8+ T cell potential in chronic hepatitis B virus infection81
Striving to optimize colorectal cancer prevention81
Microbial cues stimulate linear growth in undernourished mice81
Metabolic health across the ages: how microbiota members support our well-being80
Microbiota-based biomarkers and therapeutics for cancer management80
Author Correction: Current and future colorectal cancer screening strategies78
Digestive Disease Week 202278
Long-term dynamic ex vivo organ preservation77
Machine perfusion of the liver: applications in transplantation and beyond75
Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease75
Hippo signalling in the liver: role in development, regeneration and disease73
0.045073986053467